Login
Navigate Fool.com
Will AFFY beat
the market?

Affymax, Inc. (NASDAQOTH: AFFY)

Community Rating: 1 Star: Ominous

0.10 0.00 (0.59%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.10
Previous Close $0.10
Daily Range $0.10 - $0.10
52-Week Range $0.09 - $2.03
Market Cap $3.8M
P/E Ratio 0.35
Dividend (Yield) $0.00 (0.0%)
Volume 18,100
Average Daily Volume 912,856
Current FY EPS $0.00

How do you think AFFY
will perform against the market?

Top AFFY Bull/Bear Pitches

 

dkoeper (0)
Submitted April 7, 2011

Hematide will get approved in the dialysis setting where its phase 3 clinical trials showed a trend toward superiority when compared with aranesp. The dialysis market is much larger than the non-dial … More

0 Replies Reply Report this Post
 

NetscribeBiotech (< 20)
Submitted March 27, 2007

Affymax is a biopharmaceutical company creating peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The company was spun out from GlaxoSmithKline in 2001. Th … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

Sector

Healthcare

Industry

Drugs

Affymax, Inc. (AFFY) Description

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions. Website: http://www.affymax.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks